SR/03400/252 October 2025

Passenger van / Light commercial vehicle

Crosscamp · Base X

Country of origin: Germany
Notifying country: Germany
Counterfeit: No

Open the alert on the European Commission website ↗

What is the danger

The heater's exhaust system may work loose and come into contact with the fuel tank and/or the AdBlue tank. This may damage one or both tanks and cause a fuel spillage. Liquid fuel and/or fuel vapour that accumulates near a sufficiently hot surface may ignite and cause a fire under the vehicle floor.

Requirements breached

The product does not comply with the Regulation on the approval and market surveillance of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles.

Measures taken

Recall of the product from end users Voluntary measuresTaken by: Manufacturer

Product

Description: Passenger van / Light commercial vehicle.
Brand: Crosscamp
Model / type: UMB001e1*2018/858*00321*00-*01
Barcode: 59155
Batch: 23.06.2022 - 25.07.2024

Original source

Data comes from the official Safety Gate system of the European Commission.

Alert number: SR/03400/25 ↗
Weekly report: Report-2025-40
Published: 2 October 2025
Modified: 27 August 2026
Corrigendum: Notification SR/03408/25: at the request of the notifying authority the notification has been updated with additional information on the adopted measures. Notification SR/03405/25: at the request of the notifying authority the notification has been updated with additional information on the adopted measures. Notification SR/03404/25: at the request of the notifying authority the notification has been updated with additional information on the adopted measures. Notification SR/03402/25: the risk description of the notification has been updated to better reflect the risk. SR/03420/25: at the request of the notifying authority the notification has been updated with new risk description and legal provisions. Notification SR/03420/25: has been withdrawn on the request of the notifying country, following presentation of new test evidence.